Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Qvents Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forums 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post a Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
    • Individual
    • Company
Qvents Qvents
Qvents
  • Home 
    • About Us 
    • Contact Us 
    • Expert Panel 
    • Tags 
  • Qvents 
    • Warning Letters 
    • 483s 
    • Recalls 
    • Import Alerts 
    • Quality Insights 
    • Tags 
  • Forums 
  • Learning Resources 
    • Upcoming Trainings 
    • Training Archives 
  • Guidelines 
  • Pharma Jobs 
    • Job Openings 
    • Post a Job
      • Jobs posted by me 
  • Users & Profiles 
  • News 
  • Login/Register
shape
shape
shape
shape

Tag: Tamil Arasu

Investigation Docs Outside EDMS, Hold Ti

Authored by: Venkiteswaran.T.K, Subrangshu Chourdhary, Srinivas Churya Jubilant Generics Roorkee facility was inspected in January

Qvents Team
November 13, 2024

Deficient Method Validations, Aseptic ar

Cipla facility at Verna, Goa was audited by USFDA during June 2024 ending with issuance

Qvents
June 30, 2024

FDA 483 to DRL : Issues in Analytical Va

USFDA 483 issued to Dr.Reddys (DRL) API unit in Pydibhimavaram, India cites failure to validate

Qvents
June 24, 2024

FDA 483 to Jubilant : Data Integrity con

USFDA inspected Jubilant Generics Limited facility in Roorkee, India, from January 25th to February 2nd,

Qvents
April 11, 2024
  • Facebook
  • LinkedIn
  • Twitter

Search Posts

Latest Posts

USFDA 483 Cites Piramal Pharma for Investigation Deficiencies, Procedural Non-Compliance
 March 13, 2025
Contamination Control and Data Integrity Issues: Granules India Receives USFDA Warning Letter
 March 7, 2025
Janssen’s Korea Vaccine Unit USFDA 483 Cites Aseptic Operations Not in Control
 February 26, 2025
Facility Registration Violations, Refusal of Inspection: Jagsonpal Issued Warning letter
 February 22, 2025
Purified Water System Qualification and Control: USFDA Expectations
 February 11, 2025
footer shape 1
footer shape 2
 Quick Links 
  • Forums
  • Warning Letters
  • 483s
  • Recalls
  • Import Alerts
  • Quality Insights
 
  • News
  • Guidelines
  • Pharma Jobs
  • Job Openings
  • Post a Job
 
  • Users & Profiles
  • Trainings and Webinar
  • About Us
  • Contact Us
  • Facebook
  • LinkedIn
  • Twitter

© 2023 All Rights Reserved by Qvents

  • Terms and Conditions
  • Privacy Policy